The Statement offered a vote of confidence and recognition of the crucial role EIS and VCT plays in stimulating the flow of capital to early -stage, high growth UK companies and driving greater overall economic expansion.
Brouhaha’s latest production ‘Boys Swallows Universe’ releases new trailer.
Arecor’s ongoing progress from their licensed platform Arestat™ triggers milestone payment from Inhibrx Inc.
In the ever-evolving realm of healthcare and pharmaceuticals, the intricate dance between innovation and investment shapes the trajectory of ground-breaking discoveries and patient-centric advancements. Deep Dive editor Eloise McLennan sat down with Calculus Capital’s investment director, Liz Klein, to discuss the dynamic world where capital meets compassion.
Laverock Therapeutics secures £1m funding via the Innovate UK Investor Partnerships Future Economy programme, supported by UKI2S
Richard Moore, Co-Head of Investments, gives his analysis on how a higher bank rate may affect the investment decisions made, and his outlook for the portfolio.
Oxford BioTherapeutics’s partner has dosed first patient in phase 2 trial that has potential to revolutionise treatment.